The funding round was led by Development Partners International and included participation from Google, Visa, and IFC.
Lightrock
Venture CapitalLightrock is a global private equity platform backing purpose-driven entrepreneurs tackling global challenges. The firm invests in scalable and technology-driven business models focused on people, planet, and productivity themes across multiple regions.
Portfolio
5
companies
Investment by month
By category
- MedTech£558M
- FinTech£176M
- AI/ML£41.6M
- CleanTech£31.7M
By location
- Cambridge£558M
- London£176M
- Oxford£41.6M
- England£31.7M
Portfolio companies
CMR Surgical
CMR Surgical manufactures the Versius system for robotic minimal access surgery.
Moniepoint
Moniepoint offers a digital platform combining payments, banking, credit, and business management tools for businesses.

Selina Finance
Selina Finance offers home equity lines of credit to unlock property wealth for UK homeowners.
Ultromics
Ultromics develops artificial intelligence tools to detect hidden heart disease.
Velocys
Velocys develops technology to produce sustainable aviation fuel for the aviation sector.
Team

Ash Puri
Growth Investor
Ash brings investment experience from roles at Lightrock, TempoCap, and Episode 1 Ventures, alongside entrepreneurial background.
Umur Hursever
Partner
Recent investments
Ultromics raises $55m in Series C funding led by Lightrock, Legal and General, and Allegis Capital to expand its artificial intelligence diagnostics platform.
The Oxford spinout secured backing from a group of healthcare investors to scale its EchoGo heart disease detection technology.
"Hospitals already possess the data; they just lack the tools to unlock its full diagnostic potential."
The funding round was backed by Carbon Direct Capital, Lightrock, GenZero, and Kibo Investments following the company going private.
"production capacity and leadership team"
The upsized funding round was led by existing backers including Ally Bridge Group and Lightrock.
"Versius is very well suited to our needs as a world-leading thoracic surgery department. We have successfully helped patients get the benefit of robotic assisted surgery and we look forward to developing our robotics programme working with CMR and other centres around the world as the adoption of Versius continues."
Lightrock led the equity portion of the round alongside debt financing from Goldman Sachs and GGC to fund expansion.
"Historically, homeowners across the UK have been underserved when it comes to accessing wealth created from their largest asset – their home. Selina’s disruptive lending model allows consumers to unlock previously inaccessible capital, whilst having the flexibility to utilise the lending facility and return as per convenience. The team at Selina have achieved impressive growth with over $100m in loans issued since founding in 2019. Lightrock is delighted to be backing such an innovative team and looks forward to supporting Selina as it disrupts traditionally inflexible lenders."
